Development of novel isatin–nicotinohydrazide hybrids with potent activity against susceptible/resistant Mycobacterium tuberculosis and bronchitis causing–bacteria

Joining the global fight against Tuberculosis, the world's most deadly infectious disease, herein we present the design and synthesis of novel isatin-nicotinohydrazide hybrids (5a–m and 9a–c) as promising anti-tubercular and antibacterial agents. The anti-tubercular activity of the target hybri...

Descripción completa

Detalles Bibliográficos
Autores principales: Elsayed, Zainab M., Eldehna, Wagdy M., Abdel-Aziz, Marwa M., El Hassab, Mahmoud A., Elkaeed, Eslam B., Al-Warhi, Tarfah, Abdel-Aziz, Hatem A., Abou-Seri, Sahar M., Mohammed, Eman R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801109/
https://www.ncbi.nlm.nih.gov/pubmed/33406941
http://dx.doi.org/10.1080/14756366.2020.1868450

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801109/
https://www.ncbi.nlm.nih.gov/pubmed/33406941
http://dx.doi.org/10.1080/14756366.2020.1868450

Ejemplares similares